196 related articles for article (PubMed ID: 7706296)
21. Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family.
Culouscou JM; Remacle-Bonnet M; Carlton GW; Plowman GD; Shoyab M
Growth Factors; 1992; 7(3):195-205. PubMed ID: 1333777
[TBL] [Abstract][Full Text] [Related]
22. Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity.
Sato K; Nakamura T; Mizuguchi M; Miura K; Tada M; Aizawa T; Gomi T; Miyamoto K; Kawano K
FEBS Lett; 2003 Oct; 553(3):232-8. PubMed ID: 14572630
[TBL] [Abstract][Full Text] [Related]
23. Epiregulin: roles in normal physiology and cancer.
Riese DJ; Cullum RL
Semin Cell Dev Biol; 2014 Apr; 28():49-56. PubMed ID: 24631357
[TBL] [Abstract][Full Text] [Related]
24. Rat Sertoli cells secrete a growth factor that blocks epidermal growth factor (EGF) binding to its receptor.
Holmes SD; Spotts G; Smith RG
J Biol Chem; 1986 Mar; 261(9):4076-80. PubMed ID: 3005317
[TBL] [Abstract][Full Text] [Related]
25. Partial purification of a major type of rat prostatic growth factor: characterization as an epidermal growth factor-related mitogen.
Nishi N; Matuo Y; Wada F
Prostate; 1988; 13(3):209-20. PubMed ID: 3264909
[TBL] [Abstract][Full Text] [Related]
26. Chemical synthesis and biological activities of the EGF-like domain of mouse schwannoma-derived growth factor (SDGF).
Takenouchi T; Kadosaka M; Shin SY; Munekata E
Int J Pept Protein Res; 1995 Nov; 46(5):391-6. PubMed ID: 8567183
[TBL] [Abstract][Full Text] [Related]
27. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes.
Shelly M; Pinkas-Kramarski R; Guarino BC; Waterman H; Wang LM; Lyass L; Alimandi M; Kuo A; Bacus SS; Pierce JH; Andrews GC; Yarden Y
J Biol Chem; 1998 Apr; 273(17):10496-505. PubMed ID: 9553109
[TBL] [Abstract][Full Text] [Related]
28. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth.
Song WX; Vacca MF; Welti R; Rintoul DA
J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342
[TBL] [Abstract][Full Text] [Related]
29. Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor peptide) with epidermal growth factor for binding to 3T3 fibroblasts.
Fukuoka S; Fushiki T; Kitagawa Y; Sugimoto E; Iwai K
Biochem Biophys Res Commun; 1987 Jun; 145(2):646-50. PubMed ID: 3496093
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte conditioned medium modulates the response of primary rat hepatocyte cultures to epidermal growth factor.
Skouteris GG; Kaser MR
Biochim Biophys Acta; 1991 Oct; 1095(2):169-74. PubMed ID: 1932136
[TBL] [Abstract][Full Text] [Related]
31. Biological actions of the epidermal growth factors-like domain peptides of mouse schwannoma-derived growth factor and human amphiregulin.
Takenouchi T; Kadosaka M; Shin SY; Munekata E
J Pept Res; 1999 Feb; 53(2):120-5. PubMed ID: 10195449
[TBL] [Abstract][Full Text] [Related]
32. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.
Liang M; Garrison JC
Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749
[TBL] [Abstract][Full Text] [Related]
34. Rat epidermal growth factor: complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity.
Simpson RJ; Smith JA; Moritz RL; O'Hare MJ; Rudland PS; Morrison JR; Lloyd CJ; Grego B; Burgess AW; Nice EC
Eur J Biochem; 1985 Dec; 153(3):629-37. PubMed ID: 3000782
[TBL] [Abstract][Full Text] [Related]
35. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.
Kawamoto T; Sato JD; Le A; Polikoff J; Sato GH; Mendelsohn J
Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1337-41. PubMed ID: 6298788
[TBL] [Abstract][Full Text] [Related]
36. Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis.
Shimoyama Y; Gotoh M; Ino Y; Sakamoto M; Kato K; Hirohashi S
Jpn J Cancer Res; 1991 Nov; 82(11):1263-70. PubMed ID: 1721615
[TBL] [Abstract][Full Text] [Related]
37. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.
Bremer EG; Schlessinger J; Hakomori S
J Biol Chem; 1986 Feb; 261(5):2434-40. PubMed ID: 2418024
[TBL] [Abstract][Full Text] [Related]
38. The epidermal growth factor receptor is coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rat hepatocytes.
Liang MN; Garrison JC
J Biol Chem; 1991 Jul; 266(20):13342-9. PubMed ID: 1649188
[TBL] [Abstract][Full Text] [Related]
39. Different response to epidermal growth factor of hepatocytes in cultures isolated from male or female rat liver. Inhibitor effect of estrogen on binding and mitogenic effect of epidermal growth factor.
Francavilla A; Ove P; Polimeno L; Sciascia C; Coetzee M; Pellici R; Todo S; Kam I; Starzl TE
Gastroenterology; 1987 Sep; 93(3):597-605. PubMed ID: 3497071
[TBL] [Abstract][Full Text] [Related]
40. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.
Thompson SA; Higashiyama S; Wood K; Pollitt NS; Damm D; McEnroe G; Garrick B; Ashton N; Lau K; Hancock N
J Biol Chem; 1994 Jan; 269(4):2541-9. PubMed ID: 8300582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
